Article Text

Download PDFPDF
Case of organising pneumonia in HIV infection
  1. Momoko Yamauchi1,
  2. Nobuhiro Kanie1,
  3. Kensuke Takahashi1 and
  4. Shungo Katoh2
  1. 1Department of Clinical medicine, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan
  2. 2General Internal Medicine and Clinical Infectious Diseases, Fukushima Medical University, Fukushima, Japan
  1. Correspondence to Dr Momoko Yamauchi; yamamomo{at}nagasaki-u.ac.jp

Abstract

A man in his 50s presented to his doctor with a fever, sore throat, cough, dysgeusia and dyspnoea of several days’ duration. Tests for HIV antigen, HIV antibody and HIV PCR were positive. He was referred to our hospital for initiation of antiretroviral therapy and bronchoscopy to clarify the cause of an abnormal lung shadow on chest CT. He was diagnosed with organising pneumonia, with concurrent HIV infection. His pulmonary lesions were remitted spontaneously, and he was administered a fixed-dose combination of tenofovir (50 mg), emtricitabine (200 mg) and bictegravir (25 mg) for HIV. This is a rare report of organising pneumonia with HIV infection. Physicians need to consider organising pneumonia when lung opacity is observed in a patient with HIV infection.

  • HIV / AIDS
  • interstitial lung disease

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors MY, NK, KT, SK contributed in drafting the article and reviewing literature and writing the manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.